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Age-related loss of skeletal muscle mass and strength or sarcopenia is attributed to the high level of oxidative stress and inadequate
nutritional intake. 'e imbalance in oxidative status with increased production of free radicals results in damage to the DNA
which leads to cell dysfunction. 'is study aimed to determine the effect of Zingiber officinale Roscoe (ginger) on muscle
performance and bone integrity in Sprague Dawley (SD) rats. SD rats aged three (young), nine (adult), and twenty-one (old)
months old were treated with either distilled water or ginger extract at a concentration of 200mg/kg body weight (BW) daily for 3
months via oral gavage. Muscle performance was assessed at 0, 1, 2, and 3 months of treatment by measuring muscle strength,
muscle function, and bone integrity while DNA damage was determined by comet assay. Muscle cell histology was analyzed by
hematoxylin and eosin (H&E) staining. Young and adult ginger-treated rats showed a significant improvement in muscle strength
after 3 months of supplementation. Bone mineral density (BMD) and bone mineral content (BMC) were increased while fat free
mass (FMM) was decreased after 3 months of ginger supplementation in young rats but not changed in adult and old ginger
supplemented groups. Interestingly, supplementation of ginger for 3 months to the old rats decreased the level of damaged DNA.
Histological findings showed reduction in the size of muscle fibre and fascicles with heterogenous morphology of the muscle fibres
indicating sarcopenia was evident in old rats. Treatment with ginger extract improved the histological changes even though there
was evidence of cellular infiltration (mild inflammation) and dilated blood vessels. In conclusion, Z. officinale Roscoe prevents
DNA damage and improves muscle performance and bone integrity in SD rats indicating its potential in alleviating oxidative
stress in ageing and thus delaying sarcopenia progression.
1. Introduction
Sarcopenia is a common disease that occurs among the
elderly which normally affect people aged 60 years old and
above. 'is disease is related to the loss of skeletal muscle
mass and strength which occurs with advancing age [1].
Statistics has shown that 5 to 13% of elderly, aged 60 to 70
years, are affected by sarcopenia [2]. 'is number increases
to 11 to 50% for those aged 80 years and above. A previous
study showed that this muscle deterioration commonly
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occurred among older males as compared to females [3]
which could be characterized by the decrement of muscle
mass, muscle strength, and physical performance [4].
Currently, sarcopenia has become a greater problem among
the elderly because this disease contributes to the reduction
of life expectancies by increasing the risk of frailty, fall,
morbidity, and mortality. 'e cause of sarcopenia is mul-
tifactorial which involves genetic, physiological, and envi-
ronmental factors. It can be attributed to the high level of
oxidative stress, hormonal changes, sedentary lifestyle, and
inadequate nutritional intake [5]. However, high level of
oxidative stress is the main contributor to this muscle de-
terioration disease [6].
Oxidative stress refers to the imbalance between reactive
oxygen species (ROS) production and antioxidant defence
[7]. ROS including hydrogen peroxide (H2O2), hydroxyl
radical (.OH), nitric oxide (NO), and superoxide anion (O2–)
can be produced from endogenous sources such as mito-
chondria, endoplasmic reticulum, and cytochrome c as well
as from exogenous sources such as pollution, ultra violet
(UV) light, and heavy metals [8, 9]. Excessive production of
ROS in the body will result in oxidative damage to several
types of biological molecules such as proteins, DNA, car-
bohydrates, and lipids. Oxidative damage to DNA and
protein could cause alteration of DNA transcription as well
as loss of DNA repair capacity [10]. Meanwhile, oxidative
damage to lipids results in increment of lipid peroxidation
[11]. 'e accumulation of these molecular damages could
lead to mitochondrial dysfunction, mutation, alteration of
cell growth, and differentiation as well as apoptosis. Finally,
the accumulation of these damages could alter the balance
between synthesis and degradation of skeletal muscle pro-
tein which contributes to the pathogenesis of loss of muscle
mass disease including sarcopenia [12]. Currently, several
strategies have been introduced in order to combat these
conditions such as nutritional supplements, hormonal
therapy, and physical exercise which have shown positive
effects on muscle mass and strength [13–15].
Ginger (Zingiber officinale Roscoe) is one of the tradi-
tional herbs or spices that has been studied as an antioxidant
agent against oxidative stress in the pathogenesis of de-
generative diseases. Ginger consists of several bioactive
compounds such as 6-gingerol, 6-shogaol, 10-gingerol,
gingerdiones, gingerdiols, paradols, 5 diacetoxy-6-ginger-
dioal, and 12-gingerol that contribute to many therapeutic
effects including antioxidant, antibacterial, anticancer, anti-
inflammatory, antidiabetic, neuroprotective, and gastro-
protective [16–18].
A previous study showed that ginger extract could ex-
hibit inhibitory effect against α-amylase, α-glucosidase, and
angiotensin-converting enzyme (ACE) activity in type 2
diabetes mellitus rats [19]. Ginger extract also prevented
lipid peroxidation, inhibited ACE activity, and reversed the
expression of inflammatory cytokines and lipid in cardio-
vascular rats [20, 21]. A study carried out by Park et al. [22]
found that 6-shogoal in ginger extract had the ability to
improve the formation of synapse in the brain and inhibit
components of inflammatory pathway such as tumour ne-
crosis alpha (TNF-α), nitric oxide (NO), cyclooxygenase-2
(COX-2), and inducible nitric oxide synthase (iNOS) in the
in vivo Parkinson disease model. 'is finding was similar to
the result from another study performed by Ha et al. [23].
However, no study has been reported which investigated
the effect of ginger extract in improving muscle performance
in ageing. 'us, this study aimed to elucidate the effect of Z.
officinale Roscoe in improving muscle performance in
Sprague Dawley (SD) rats.
2. Materials and Methods
2.1. Zingiber officinale Roscoe Preparation. Fresh ginger was
harvested from Bentong, Pahang, Malaysia. 'e extraction
process was carried out at Department of Chemical Process
Engineering, Universiti Teknologi Malaysia (UTM, Kuala
Lumpur, Malaysia), and ERP Two One Technologies &
Innovations Sdn Bhd (Subang, Malaysia). Standardized
ginger extract was isolated by using the subcritical water
extraction method at optimum temperature of 130°C for
30min with the solvent to solid ratio at 28/2ml/mg [24].'e
extract contains 6-gingerol and 6-shogaol at concentrations
of 289.531mg/mL and 15.466mg/mL, respectively. Ginger
was freeze-dried to form powder and stored at −20°C before
use.
2.2. Animals. For the main study, the SD rats were divided
into three groups: 18 male young 3-month-old SD rats, 18
male adult 9-month-old SD rats, and 18 male aged 21-
month-old SD rats. 'e rats were purchased from Universiti
Kebangsaan Malaysia Laboratory Animal Resource Unit
(LARU). Each age group of rats was further allotted into two
groups: Group 1 was control group which was given 1ml of
distilled water (n= 8) and Group 2 was given 200mg/kg/
body weight (BW) daily of Z. officinale Roscoe (n= 10) for
three months. Each rat was randomly kept in individual
Sealsafe® Plus Rat IVC Green Line (TECHNIPLAST,
Varese, Italy) cage in animal care facility and allowed to
acclimatize for one week before administration of the
treatment. 'roughout the study, the rats were maintained
in animal care facilities with temperature of 24°C and 12 h of
light and dark cycle. 'e rats were also provided with rat
pellet (Gold Coin, Malaysia) and water ad libitum. 'e rat
pellet is composed of minimum 22.0% crude protein con-
tent, maximum 5.0% crude fibre content, minimum 3.0%
crude fat content, maximum 13.0% moisture, maximum
8.0% ash, 0.8%–1.2% calcium, 0.6%–1.0% phosphorus, and
approximately 49.0% nitrogen-free extract. Kenaff (Muhaaz
Enterprise, TerengganuMalaysia) was used as the bedding of
the rats which was changed twice per week.'e animals were
tested based on their groups, starting from Group 1 and
followed by Group 2 for each test performed. 'e experi-
mental design was consented by the Universiti Kebangsaan
Malaysia Animal Ethics Committee (UKMAEC Approval
Number: BIOK/PP/2018/SUZANA/14-MAY/924-JUNE-
2018-MAY-2020). 'e experimental protocol for this re-
search is depicted in Figure 1. 'e number of animals was
chosen based on previous study that used seven rats for
control and eight rats for the treated group to study the effect
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of gelam honey and ginger, along with the approval from
UKMAEC [25].
2.3. Pilot Study. In the pilot study, three female rats were
used. 'e main purpose of this pilot study was to select the
optimum dosage to be used in the main study and to
minimize the number of rats to be used. 'e starting dosage
of Z. officinale Roscoe in this pilot study was 5mg/kg/BW
followed by 50, 300, and 2000mg/kg/BW sequentially for
every five days. Blood was drawn on days 6, 11, 16, and 21 for
liver function test.
2.4. Clinical Observations. 'e rats were observed individ-
ually at 0.5, 1, 2, 3, and 4 h after administration of Z. offi-
cinale Roscoe extract. 'e rats were then observed after 24 h,
followed by observation twice daily thereafter for the du-
ration of 21 days for mortality and clinical toxicity signs.'e
signs of clinical toxicity include changes on skin, fur, eyes,
and mucous membrane, behavioural pattern, tremors, sal-
ivation, diarrhoea, occurrence of secretion, excessive
grooming, repetitive circling, and bizarre behaviour such as
self-mutilation and walking backwards. 'roughout the
experimentation, the rats were also closely monitored for
any signs of pain which include excessive licking or
scratching, redness and swelling at any site, anorexia which
was indicated by the absence of faeces, struggling, squealing,
convulsions, twitching, tremors, weakness, teeth grinding,
hunched up, unwilling to move, and favouring a limb. 'e
other signs of pain include decrease in appetite which were
evidence by few faeces, biting of affected body part, reluc-
tant to move, increased respiration, change in bowel or
urinary activities, and porphyrin discharge which was shown
by red-brown pigment around eyes and nostrils. 'e BW for
each rat was recorded on days 0 (prior to dosing), 6, 11, 16,
and 21.
2.5.AcuteToxicity Study. Twelve female SD rats were used in
the toxicity study. From the pilot study, it was found that the
highest dose of 2000mg/kg/BW Z. officinale Roscoe extract
did not cause mortality and toxicity signs. 'us, the dosage
of 200mg/kg/BW Z. officinale Roscoe extract was selected
for the main study. 'us, this dose was used for acute
toxicity study and treatment was given either orally once
(single unrepeated dose) or orally daily (repeated dose) for
14 days. 'e extract was freshly prepared before adminis-
tration and calculated based on the current BW of the rat.
'e rats were then observed individually at 0.5, 1, 2, 3, 4, and
24 h, followed by observation twice daily thereafter for the
duration of 14 days for mortality and clinical toxicity signs.
'e BW for each rat was recorded on days 0 (prior to
dosing), 7, and 14. Blood was also collected on days 0, 7, and
14 for liver function test. After the animals were sacrificed,
all organs were then collected, weighted, and observed for
any sign of toxicity.
2.6. Grip Strength Test. 'e front paws and hind paws grip
strength were measured using Bioseb’s Grip Strength Test
(USA) machine.'e grip strength was used to determine the
maximal peak force developed by a rat when it pulled out the
metal bar. 'e machine was set up on a strong and stable
table. 'e rat was allowed to grasp the metal bar by its front
paws when it was pulled by the tail backwards in horizontal
plane. Peak tension, the force applied to the bar just before it
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Figure 1: 'e timeline for the experimental protocol.
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three times and the machine would record the highest peak
tension. 'en, the same procedure was repeated for the hind
paw grip strength measurement.
2.7. Rotarod Test. An automated rotarod (Med Associates,
St. Albans, VT, USA) was used to assess muscle function by
evaluating grip strength and balance. Each rat was placed on
the rotating cylinder with a constant speed rotation (16 rpm)
over 300 s where they had to walk to maintain their position
on the cylinder. Test ended when rat fell from the rod, and
the latency to fall was recorded (max 300 s). Each rat was
tested three times with 10min of rest between each test. Data
are presented as the average of the three tests. 'e test was
performed at 0, 1, 2, and 3 months of supplementation.
2.8. Measurement of Bone Mineral Density, Bone Mineral
Content, and Lean BoneMineral Content. For the analysis of
computerized tomography of bone density, the entire body
of the rat was scanned by applying dual energy X-ray
absorptiometry (DXA) (Hologic Discovery W, Bedford,
USA). 'e rat was first anesthetized and left for 10 to 15min
for its sedative effect. 'e sedated rat was then laid down on
the X-ray platform and scanning was performed within
3min duration. As scanning was performed, a large radi-
ating scanning arm was moved over the rats and a low-dose
X-ray beam was passed through the rats. 'ese radiation
changes were converted to the quantification of bone
mineral density (BMD), bone mineral content (BMC), lean
BMC, and percentage of fat free mass (FFM) of each rat by
the Hologic software.
2.9. Open Field Test. 'e rat was carried to the test room in
its home cage and was handled by the base of their tails at all
times. 'e open field test was carried out in a square and
black painted wooden box of 60 cm× 60 cm. 'e rat was
placed into one of the four corners facing towards the wall of
the box and allowed to explore the field for 5 minutes in
which its movement was recorded by a video camera
mounted to the ceiling. 'e rat was simultaneously assessed
using HVS Image Software 2017, based on the parameters of
interest which include total path length and percentage of
time moving. After the 5-minute test, the rat was returned to
its home cage and the wooden box was wiped with 70%
ethanol and permitted to dry between tests.
2.10. Blood Collection. Blood was withdrawn from each rat
on days 0, 30, 60, and 90 of treatment by orbital sinus
collection methodology. 'e rat was anesthetized prior to
blood collection and was handled with thumb and forefinger
of the left hand. Skin around the rat’s eye was pulled out until
the eye bulged out and a capillary tube was inserted with
slight thumb pressure into the medial canthus of the eye at
30° angle to the nose. Blood was flown through the capillary
tube after puncturing through the tissue and plexus/sinus. A
total of 3ml of blood was collected into EDTA tube before
gently removing the capillary tube. Bleeding was then
stopped by applying a gentle pressure by the finger and
wiped with sterile cotton. 'e collected blood was later
centrifuged and plasma was kept in −80°C freezer for further
analysis.
2.11. Analysis of Damaged DNA by Comet Assay. Comet
assay was performed as described by Singh et al. [26] with
slight modification. Fully frosted microscope slides were
coated with a thin layer of 0.6% normal melting point
agarose (Sigma-Aldrich, St. Louise, MO, USA) and placed at
room temperature for 10 minutes. Once the first agarose
layer was solidified, a mixture of 5 μL of whole blood with
0.6% low melting point agarose (Sigma-Aldrich, St. Louise,
USA) was applied as the second layer. 'en, the slides were
immersed in chilled fresh lysing solution (2.5M NaCI,
100mMNa2EDTA-2H2O, 10mM Tris at pH 10, 1% sodium
N-lauroylsarcocinate, 1% Triton X-100, and 10% dime-
thylsulfoxide) for 1 h at 4°C. After lysis, the slides were
placed in a horizontal electrophoresis tank filled with chilled
fresh buffer (0.3M NaOH and 1mM Na2 EDTA) for 20
minutes to allow unwinding of the DNA followed by 20
minutes electrophoresis at 25V with the current adjusted to
300mA. After electrophoresis, the slides were rinsed twice
with neutralization buffer (0.4M Tris Base, pH 7.5) to
neutralize the excess alkali and were stained with ethidium
bromide (20 μg/mL) (Sigma-Aldrich, St. Louise, MO, USA).
'en, the slides were kept at room temperature to dry for
later analysis. 'e slide was examined at 40x magnifications
using a fluorescence microscope (Olympus, UK) where
photomicrographs of 500 randomly selected nonoverlap-
ping cells on each slide were captured. 'e slides of each rats
were made in triplicate. All of the above procedures were
performed in the dark. Comet images were analyzed using
CASP software (CASP, Wroclaw, Poland). Percentages of
tail DNA, tail length, tail moment, and olive tail moment
were recorded to evaluate DNA damage.
2.12. Euthanization of Animals. 'e anaesthesia agents used
in this study were KTX agents which are the combination of
ketamine, xylazine, and zoletil-50 (tiletamine and zolaze-
pam). 'e KTX agents were administered based on 0.1ml/
250 g of rat BW for each rat by intraperitoneal injection, at
the lower right quadrant of the abdomen due to its rapidity,
efficacy, and minimal pain, fear, and distress. 'e rats were
then left for about 30min for the KTX agents to give their
sedative effect. 'is was observed by clinical signs, including
disorientation and loss of consciousness, depression of
respiration or rapid irregular breathing, progressively de-
clined heart rate and blood pressure, urination, and defe-
cation. Later, the rats were euthanized by decapitation
method using decapitator (Modiezham Sdn. Bhd., Kuala
Lumpur, Malaysia).
2.13. Collection of Organs. All rats were fastened overnight
on day 90 before sacrificing for necropsy examination. 'e
organs such as the heart, liver, kidneys, brain, and quad-
riceps muscle were dissected from the sacrificed rats. All
organs were washed with 90% normal saline to remove any
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adherent tissue and later weighted. 'e weight of the organs
was taken as quickly as possible to avoid drying, and they
were analyzed in relative to the BW of the animals.
2.14. Histological Analysis. Quadriceps muscle tissues were
fixated in 10% neutral formalin to preserve it permanently.
'e tissue was cut into small section and placed inside plastic
cassette to hold the tissue while being processed by auto-
mated vacuum tissue processor (STP 120 Spin Tissue Pro-
cessor, 'ermo Fisher Scientific, Massachusetts, USA).
'en, the tissue was embedded to be made as block of
paraffin (Surgipath® Paraplast® from Leica Biosystems
Richmond Inc., Illinois, USA). 'e tissue was later cut into
section of 5 μM by using Leica RM2135 Manual Rotary
Microtome (Leica, Nussloch, Germany). 'e cut sections
were then floated on a 38°C preheated warm water bath
(Leica HI1210 Water Bath, Leica, Nussloch, Germany),
before picking it up on glass microscopic slide. 'e glass
slide with tissue section attached was further warmed at 50°C
for 30min in Memmert UN50 Universal Oven (Memmert,
Buechenbach, Germany). Haematoxylin and eosin (H&E)
staining was then performed.'e stained section of the slide
was mounted by DPX mountant (VWR International Ltd.,
Poole, England) and covered with thin cover slides. 'e
staining later was viewed under dissecting BX53 Microscope
(Olympus, Tokyo, Japan) with built-in light source and
camera attachment linked to LCD for the visualization of
H&E staining.
2.15. Statistical Analysis. All data were expressed as
mean± standard deviation (SD); a p value of <0.05 was
considered statistically significant. SPSS software version 25
was used to carry out the statistical analysis. Data acquired
were analyzed by using one-way ANOVA followed by a post
hoc Bonferroni test.
3. Results
3.1. Clinical Observations. No physical and behavioural
changes were observed on all treated rats after oral ad-
ministration of Z. officinale Roscoe for 14 and 21 consecutive
days in both pilot and toxicity studies. No mortality was
recorded in both studies.
3.2. Rats’ Body Weight of Pilot and Toxicity Studies. No
change was observed on the BW of rats in the pilot study
from day 0 till day 21 (Figure 2(a)). For acute toxicity study,
the BW of the rats was retained throughout the study from
day 0 till day 14 of the study (Figures 2(b) and 2(c)).
3.3. Relative Organ Weight (ROW) of Pilot and Toxicity
Studies. 'e ROW of pilot study, single unrepeated dose of
acute toxicity study, and daily dose of acute toxicity study is
shown in Figure 3. 'e ROW of the lung for daily dose of
acute toxicity study was significantly decreased compared to
ROW of lung for pilot study (p< 0.05). However, the ROW
of the liver for daily dose of acute toxicity study was
significantly increased as compared to ROW of liver for pilot
study (p< 0.05).'e ROWof the brain for single unrepeated
dose and daily dose of acute toxicity study was significantly
decreased as compared to the ROW of the brain for pilot
study (p< 0.05).
3.4. Liver Function Test. 'e liver function test for pilot and
acute toxicity studies on various days is shown in Table 1.
'e levels of total protein, albumin, globulin, albumin/
globulin ratio, total bilirubin, aspartate transaminase, ala-
nine transaminase, alkaline phosphatase, and gamma-glu-
tamyl transferase of rats in the pilot study and single
unrepeated dose of toxicity study were not significantly
different between the different days. However, the levels of
total protein and globulin on days 7 and 14 of daily dose of
toxicity study were significantly increased compared to day 0
and day 7, respectively (p< 0.05).
3.5. Body Weight and Relative Organ Weight of Main Study.
'e BW of young, adult, and old rats was significantly in-
creased within and between the group of treatments
(Figure 4(a)). BW data were analyzed using a one-way re-
peated measure ANOVA followed by Bonferroni corrected
t-test with p value< 0.05.
Measurement of the organ weight showed that the ROW
of spleen and brain was significantly increased in young rats
treated with ginger as compared to untreated control
(p< 0.05) (Figure 4(b)). For old rats however, the ROW of
right kidney was significantly decreased compared to un-
treated control (p< 0.05) (Figure 4(d)).
3.6. Measurement of Grip Strength. 'e grip strength of front
paws was significantly decreased at 3 months in control adult
rats as compared to control young rats (p< 0.05) (Figure 5(a)).
Treatment with ginger significantly increased the grip strength
at 1, 2, and 3 months of young rats as compared to untreated
control (p< 0.05). Treatment with ginger significantly in-
creased the grip strength at 3months of adults rats as compared
to untreated control adult rats (p< 0.05).
'e grip strength of hind paws was significantly in-
creased at 0 and 2 months in young rats treated with ginger
as compared to untreated control young rats (p< 0.05)
(Figure 5(b)). A similar increase was observed in the grip
strength at 0 months in control adult rats while it decreased
at 3 months as compared to control young rats (p< 0.05).
Treatment with ginger significantly increased the hind paws
grip strength at 0 and 3 months in adult rats as compared to
untreated control adult rats (p< 0.05). 'e grip strength of
hind paws was significantly decreased at 1 and 3 months in
control old rats as compared to control young rats (p< 0.05).
3.7. Measurement of Muscle and Bone Integrity. Muscle and
bone integrity were represented by bone mineral content,
bone mineral density, lean bone mineral content, and
percentage of fat free mass (Figure 6). Bone mineral content
was significantly decreased at 3 months in young rats
treated with ginger as compared to untreated control young
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rats (p< 0.05) (Figure 6(a)). In control adult rats, bone
mineral content was significantly increased at 2 and 3
months while in control old rats it was significantly in-
creased at 1, 2, and 3 months as compared to control young
rats (p< 0.05).
Bone mineral density was significantly decreased at 1
and 3 months in young rats treated with ginger as
compared to untreated control young rats (p< 0.05)
(Figure 6(b)). In control adult rats, bone mineral density
was significantly increased at 0, 1, 2, and 3 months while
in control old rats, it was significantly increased at 0 and 1
month as compared to untreated control young rats
(p< 0.05).
Lean bone mineral content was significantly decreased at
0, 1, and 3 months in young rats treated with ginger as
compared to untreated control young rats (p< 0.05)
(Figure 6(c)). In control adult rats, lean bone mineral content
was significantly increased at 0, 1, and 3 months while in
control old rats, it was significantly increased at 0, 1, and 3









































Figure 3: Relative organ weight of pilot study (n� 3), single unrepeated dose of acute toxicity study (n� 6), and daily dose of acute toxicity
study (n� 6).'e data are presented as mean± SD; ap< 0.05, significantly different compared to pilot study; bp< 0.05, significantly different



































































Daily dose of acute toxicity study
(c)
Figure 2: 'e body weight of (a) pilot study (n� 3), (b) single unrepeated dose of acute toxicity study (n� 6), and (c) daily dose of acute
toxicity study (n� 6). 'e data are presented as mean± SD. No significant changes were found.
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Percentage of fat free mass was significantly increased at
0, 1, and 2 months in control adult rats as compared to
untreated young control rats (Figure 6(d)). No significant
change in the percentage of fat mass was observed in other
groups of rats.
3.8. Measurement of Muscle Function by Open Field Test.
No significant change was observed in total path and speed
of movement of young, adult, and old rats as measured by
the open field test (Figure 7).
3.9. Measurement of Muscle Function by Rotarod Test. No
significant change was observed in the time of fall of young,
adult, and old rats as measured by the rotarod test (Figure 8)
3.10. Analysis of Damaged DNA. Damaged DNA was
measured by comet assay in old rats which is represented by
tail length, tail moment, tail DNA percentage, and olive
moment. 'e tail length, tail moment, and olive moment
were significantly increased at 1 month but decreased at 2
and 3 months in old rats treated with ginger (p< 0.05)
(Figure 9(a)). A similar increase was observed in tail DNA
percentage at 1 month in old rats treated with ginger but
decreased at 3 months of ginger treatment (p< 0.05).
3.11. Histological Observation. Histological examination of
H&E-stained cross sections of the quadriceps femoris
muscle revealed polyhedral-shaped fibre with acidophilic
sarcoplasm and peripherally located flat nuclei in both
young and adult control groups and also in the ginger-
treated groups (Figures 10(a), 10(b), 10(d), and 10(e)). Each
muscle fibre was surrounded by thin connective tissue of
perimysium (Figure 10, arrow).
'ere was an apparent decrease in the size and number
of the muscle fibres and fascicles in the old control group
(Figure 10(c)). 'e shape of the muscle fibres appeared
angulated and separated by a wide connective tissue
endomysium. Dilated blood vessel was also seen in between
the muscle fibres (Figure 10(c)). 'e perimysium separating
the muscle fascicles was wide.
Old rats treated with ginger showed heterogenous
morphology of polyhedral and angulated muscle fibres of
various sizes (Figure 10(f )). 'e connective tissue of
endomysium and perimysium appeared narrower in most
areas compared to that of the old control group. In lon-
gitudinal section, cellular infiltration was observed be-
tween the muscle fibres of the old control group
(Figure 11(c)) but was not apparent in the old ginger-
treated group (Figure 11(f )). Fat infiltration, disruption of
muscle fibres, vacuole formation, and centrally located
nuclei (evidence of regeneration) were not evident in all
groups.
Table 1: 'e liver function test results of pilot study, single unrepeated dose of acute toxicity study, and daily dose of acute toxicity study.








Pilot study, n� 3
Day
0
84.00± 1.00 28.00± 1.00 56.00± 1.00 0.50± 0.00 2.28± 0.99 248.00± 63.66 84.00± 17.44 251.67± 137.01 4.00± 0.00
Day
6
74.00± 6.56 24.00± 2.65 50.00± 6.93 0.50± 0.10 1.71± 0.00 235.33± 125.13 94.00± 27.87 230.33± 117.17 4.00± 0.00
Day
11
89.67± 8.62 28.00± 2.65 61.67± 6.03 0.47± 0.06 1.71± 0.00 244.67± 40.55 100.33± 26.56 230.33± 153.94 4.00± 0.00
Day
16
88.67± 22.05 27.67± 3.79 61.00± 18.33 0.50± 0.10 2.85± 1.97 241.00± 59.40 111.33± 20.40 289.00± 145.66 4.00± 0.00
Day
21
65.00± 0.00 25.00± 0.00 40.00± 0.00 0.60± 0.00 1.71± 0.00 118.00± 0.00 80.00± 0.00 162.00± 0.00 4.00± 0.00
Single unrepeated dose of acute toxicity study, n� 6
Day
0
76.50± 3.94 26.83± 1.17 49.67± 4.18 0.55± 0.05 1.71± 0.00 305.17± 70.44 96.00± 15.56 285.00± 55.95 4.00± 0.00
Day
8
78.83± 5.19 27.67± 1.86 51.17± 3.87 0.53± 0.05 1.71± 0.00 230.17± 22.13 98.00± 6.63 282.00± 71.56 4.00± 0.00
Day
15
77.17± 2.32 25.83± 1.47 51.33± 2.16 0.48± 0.04 1.71± 0.00 319.67± 59.71# 110.83± 13.93 299.50± 68.95 4.00± 0.00
Daily dose of acute toxicity study, n� 6
Day
0
71.33± 3.50 27.17± 1.17 44.17± 4.26 0.62± 0.08 1.71± 0.00 210.00± 47.72 79.00± 11.26 219.33± 43.02 4.00± 0.00
Day
8
91.17± 14.50∗ 30.67± 2.94 60.50± 11.91∗ 0.52± 0.08 2.00± 0.07 241.67± 65.09 90.83± 25.88 215.33± 56.22 4.00± 0.00
Day
15
73.67± 3.20# 28.00± 1.67 45.67± 3.83# 0.62± 0.08 1.71± 0.00 209.00± 43.72 88.00± 15.36 222.50± 43.26 4.00± 0.00
'e data are presented as mean± SD; ∗p< 0.05, significantly different compared to day 0; #p< 0.05, significantly different compared to day 8, with a post hoc
Bonferroni test.
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4. Discussion
Sarcopenia is a geriatric syndrome that involves decline of
muscle mass and strength which increases the risk of
disability, mobility loss, and mortality [27]. One of the
causes that contribute to the pathogenesis of sarcopenia is
the presence of high level of oxidative stress in the body
[28]. Generally, oxidative stress occurs when the produc-
tion of ROS is higher as compared to the production of
antioxidant. 'e overproduction of ROS could result in
DNA damage and cell dysfunction which later might
contribute to the deterioration of muscle mass and
strength. 'us, in this study, we elucidated the effect of
ginger (Z. officinale Roscoe) in improving muscle perfor-
mance in SD rats. 'ree groups of male SD rats were used
in this study which were 3-, 9-, and 21-month-old rats.
'ese three groups of rats were treated either with ginger
extract or distilled water. Muscle performance of rats was
evaluated by measuring muscle strength, muscle function,
and muscle and bone integrity while DNA damage was
measured via comet assay and histological analysis by H&E
staining.
Ginger has been extensively studied as antioxidant and
anti-inflammatory agent in various types of diseases in-
cluding diabetes, cardiovascular disease, hypertension, and
others. Ginger extract has been proven to improve the ex-
pression of antioxidant enzyme as well as restore the level of
glutathione in Alzheimer’s disease [29]. Besides, ginger
extract also exhibits a positive effect in osteoarthritis disease
by decreasing the level of TNF-α, IL-8, and hs-CRP [30, 31].
In type 2 diabetes, supplementation of powdered ginger
capsule has attenuated the level of glucose, MDA, CRP, and
insulin resistance together with the improvement of anti-
oxidant capacity and serum paraoxonase-1 [32].
Our findings showed that the ginger extract used in this
study did not cause any toxicity effect as no toxicity and
mortality were observed in the pilot and toxicity studies. No
change in BWwas observed in this study. Gross pathological
evaluations showed no signs of organs abnormalities on each
organ of the pilot and toxicity studies. Generally, the ROW
also showed no differences. 'e value of biochemical pa-
rameters of liver function test showed no differences in this
study. 'is finding was in line with another study which
























































































Figure 4: 'e (a) body weight and relative organ weight of (b) young, (c) adult, and (d) old rats. 'e data are presented as mean± SD (n� 8
(control rats); n� 10 (Z. officinale-treated rats)). ap< 0.05, significantly different compared to control young rats; cp< 0.05, significantly
different compared to control old rats, with a post hoc Bonferroni test.
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to 500mg/kg per day did not show any toxic effect to Wistar
rats in terms of hematological parameters, renal parameters,
and histopathological parameters of kidney [33]. Con-
versely, another toxicity study of 60-day subchronic ginger
supplementation reported that 10mL/kg of ginger fixed oil
induced oxidative stress, cellular toxicities, and organ’
toxicities in kidneys, liver, spleen, and lungs [34].
In this study, muscle strength was determined by the grip
strength test while muscle function was assessed by the open
field test and rotarod test. Our findings showed that muscle
strength was decreased with increasing age of the rats.
Treatment with ginger extract for 3 months was able to
increase the grip strength of young rats as early as 1 month
after treatment. However, no similar effect was observed in
adult and old rats treated with ginger. 'is could be due to
the higher muscle regenerative capacity of the young ginger-
treated rats than adult or old ginger-treated rats. 'e muscle
regenerative capacity totally depends on the regeneration of
satellite cells which slowly decreased with ageing [35]. It has
been reported that the number of satellite cells decreased as
ageing occurs [36]. A study conducted by Khor et al. [37]
reported that senescent myoblast has low proliferative ca-
pacity, which showed downregulation of myogenic differ-
entiation genes, but the expression of oxidative damage-
associated gene was increased which may contribute to the
decreased muscle regenerative capacity of adult and old
ginger-treated rats observed in this study.
'e findings on muscle strength in this study could also
be due to the accumulation of ROS in adult and old ginger-
treated rats which was higher than young ginger-treated rats.
'is is because with the advancing of age, there is over-
production of ROS in the body and the capacity to remove it
from the body was decreased [38]. A previous study reported
that the accumulation of ROS in senescent myoblast could
contribute to the modifications in the cell membrane, ex-




















































Figure 5: 'e grip strength of (a) front paws and (b) hind paws of young, adult, and old rats. 'e data are presented as mean± SD (n� 8
(control rats); n� 10 (Z. officinale-treated rats)). ∗p< 0.05, significantly different compared to control young rats on respective month;
#p< 0.05 significantly different compared to control adult rats on respective month; ap< 0.05, significantly different compared to control
young rats at 0 months; bp< 0.05, significantly different compared to control young rats at 1 month; cp< 0.05, significantly different
compared to control young rats on at 2 months; dp< 0.05, significantly different compared to control young rats on at 3 months, with a post
hoc Bonferroni test.
10 Evidence-Based Complementary and Alternative Medicine
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Bone mineral content (BMC)
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cellular metabolism and pathway [39]. 'ese cell structures
are essential in maintaining the integrity of myoblast cell
structure.
Moreover, accumulation of ROS could lead to the
content reduction of myosin protein as well as inhibit the
occurrence of transcriptional process of myostatin gene
Young control Young ginger Adult control Adult ginger Old control Old ginger
























Figure 6: 'e (a) bone mineral content (BMC), (b) bone mineral density (BMD), (c) lean BMC, and (d) percentage of fat mass of young,
adult, and old rats. Data are presented as mean± SD (n� 8 (control rats); n� 10 (Z. officinale-treated rats)). ap< 0.05, significantly different
compared to control young rats at 0 months; bp< 0.05, significantly different compared to control young rats at 1 month; cp< 0.05,
significantly different compared to control young rats at 2 months; dp< 0.05, significantly different compared to control young rats at 3
months, with a post hoc Bonferroni test.









































Figure 7: 'e (a) total path and (b) speed of movement of young, adult, and old rats. Data are presented as mean± SD (n� 8 (control rats);
n� 10 (Z. officinale-treated rats)). No significant changes were found.
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resulting in imbalanced protein synthesis and protein
breakdown [40, 41]. 'e deterioration of myosin expression
also caused dysfunction of myofilament which later can affect
the muscle performance [41]. Besides, the presence of ROS in
the body will result in decreased production of acetylcholine
in synaptic cleft that contributes to the failure of action
potential production by sarcolemma as well as affects the
neuromuscular junction which is essential in preserving
muscle strength and quality [42, 43]. 'e continuous pro-
duction of ROS also contributes to changing the morphology


































































































Figure 9: 'e level of damaged DNA of old rats was measured based on (a) tail length, (b) tail moment, (c) tail DNA percentage, and (d)
olive moment using the comet assay method. Data are presented as mean± SD (n� 8 (control rats); n� 10 (Z. officinale-treated rats)).


























Figure 8: 'e rotarod performance test of young, adult, and old rats. Data are presented as mean± SD (n� 8 (control rats); n� 10 (Z.
officinale-treated rats)). No significant change was observed.
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In this study, muscle and bone integrity were determined
by measuring bone mineral density (BMD), bone mineral
content (BMC), and fat free mass (FFM). 'e results of the
present study showed that BMC, BMD, lean BMC, and FFM
were increased with increasing age of the rats. Treatment
with ginger for three months did not cause any significant
effect to all parameters measured in all groups of rats.
However, in young rats, ginger treatment caused a reduction
in BMC, BMD, and lean BMC. 'ese observations could be
due to short-term supplementation of ginger extract in the
treated group of rats. BMD, BMC, and lean BMC are major
determinants of bone strength since they are involved in
bone structure process. As ageing occurs, there is abundant
generation of ROS with insufficient support of antioxidant
system which later gives a negative effect towards osteoblast
and osteoclast regulation [45]. 'e accumulation of
(a) (b) (c)
(d) (e) (f )
Figure 10: Cross section of H&E-stained rat muscle fibres and fascicles of the quadriceps femoris muscle. Rats treated with distilled water:
(a) young, (b) adult, and (c) old control groups. Rats treated with Z. officinale: (d) young-, (e) adult-, and (f) old-treated groups. Each muscle
fibre was surrounded by epimysium (black arrow), and the muscle fascicle was surrounded by abundant connective tissue (★). Dilated blood
vessel is shown by blue double arrows. Images were photographed at 400x magnification.
(a) (b) (c)
(d) (e) (f )
Figure 11: Longitudinal section of H&E-stained rat muscle fibres and fascicles of the quadriceps femoris muscle. Rats treated with distilled
water: (a) young, (b) adult, and (c) old control groups. Rats treated with Z. officinale: (d) young-, (e) adult-, and (f) old-treated groups. Many
nuclei are seen infiltrating the muscle fibres (oval area). Images were photographed at 400x magnification.
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oxidative stress during ageing could affect the bone turnover
by triggering imbalance production of cells responsible for
bone resorption and formation [46]. A previous study has
proven that dietary compounds with enriched antioxidant
and anti-inflammatory properties have promising bone
protective effects. A study conducted by Varela-López et al.
displayed that CoQ10 supplementation could contribute to
the lowest loss of BMD in aged rats by preventing DNA and
lipid damage [47]. In another study, they found that intake
of dried plum that consists of enriched antioxidant prop-
erties could improve alkaline phosphatase activity, insulin-
like growth factor-1 (IGF-1), and BMD in postmenopausal
women by suppressing the rate of bone turnover [48].
Moreover, blueberry supplementation in rats improved the
bone formation rate, osteoblast number, and levels of tra-
becular bone volume together with inhibition of osteoblast
senescence and bone loss [49]. Hence, long-term supple-
mentation of ginger extract may exhibit a similar effect as
other antioxidant dietary compounds in improving BMC,
BMD, and lean BMC in aged rats.
'e findings of this study also showed that treatment of
ginger for 3 months to the old rats was able to decrease the
level of damaged DNA.'is indicates the potential of ginger
in alleviating DNA damage caused by overproduction of
ROS. 'is finding was in line with current result which
found that treatment with ginger significantly increased the
grip strength of front and hind paws of young and adult rats
as compared to untreated control. 'e potential of ginger as
antioxidant agent in decreasing the level of ROS has been
reported in previous findings. A study conducted by Tung
et al. found that ginger root extract has shown antioxidant
and acetylcholinesterase inhibitory activity in Alzheimer’s
disease [50]. 'is was supported by another finding which
reported that 6-gingerol in ginger extract has the ability to
increase the expression of antioxidant enzyme as well as
restore glutathione level [29]. 'e antioxidant properties of
ginger have also been reported in a study carried out by
Fahmi et al. [51] which found that ginger extract was able to
lessen the severity of diethylnitrosamine (DEN) toxicity in
rats by increasing the level of serum high-density lipoprotein
(HDL) and plasma glutathione peroxidase (GSH-Px) ac-
tivity, accompanied by decreased low-density lipoprotein
(LDL), serum alanine aminotransferase (ALT), and alkaline
phosphatase (ALP). In another study, ginger has been
proven to attenuate lipid peroxidation with reduction of
MDA level and increase glutathione S-transferase activity in
the liver of Wistar rats [52]. 'ere was also significant re-
duction in body weight and lipid droplet deposition in the
rats’ liver.
Histological analysis carried out in this study showed
that sarcopenia is evident in the muscle of old rats but it is
still in the early stage. Apparent reduction in the size of
muscle fibre and fascicles with heterogenous morphology of
the muscle fibres and mild sequestration of cellular infil-
tration were observed. However, the full-blown sarcopenic
histological findings such as fat infiltration, mononuclear
infiltration, disruption of muscle fibre arrangement, and
vacuole formation were absent. 'ese sarcopenic changes,
however, were lesser in old rats treated with ginger extract
even though there was evidence of cellular infiltration (mild
inflammation) and dilated blood vessels. 'e sarcopenic
changes observed in old rats in this study were milder as
compared to another study which showed that muscle fibres
of diabetic rats treated with Centella asiatica have increased
in size, appeared in closely space, and become more con-
tinuous as well as the muscle fibres have been restored in
regular polygonal shape [53]. However, this result was
similar with a previous study which found that treatment
with mixed Japanese herbs known as “Dokhwalgisaeng-
tang” on disuse muscle atrophy rats has decreased the
myofibre size of the gastrocnemius muscle [54]. 'e accu-
mulation of nuclei around the myofibres was also observed
indicating the presence of inflammatory cells. 'e lesser
sarcopenic changes in old rats treated with ginger observed
in this study may indicate the ameliorative action of ginger
as antioxidant agent by enhancing structural protein syn-
thesis. 'is is because the production of excessive ROS in
skeletal muscle could cause sarcopenia leading to deleterious
structural changes by affecting the muscle fibres lipid
membrane bilayer [55]. Furthermore, the presence of excess
ROS will cause imbalance between protein synthesis and
degradation which later contributes to the reduction in
skeletal muscle fibres [56].
'e molecular finding from this study was limited as it
focused on the outcome of ginger supplementation on
muscle performance. 'erefore, further study is needed to
elucidate the molecular mechanism of ginger in improving
muscle performance. By performing a molecular study, the
exact mechanism of ginger in reducing the level of oxidative
stress in the muscle can be confirmed which can be used as a
preventative measure for muscle disease, such as sarcopenia.
However, the improvement of muscle performance in SD
rats supported by the histological findings and the reduction
of DNA damage observed in the present study strengthen
the properties of ginger as an antioxidant agent, and thus it
can be potentially used to alleviate oxidative stress and
prevent age-related muscle disease.
5. Conclusions
In conclusion, ginger or Zingiber officinale Roscoe prevents
DNA damage and improves muscle performance and bone
integrity in Sprague Dawley rats indicating its potential in
alleviating oxidative stress in ageing and thus delaying
sarcopenia progression.
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